Avir - Jupiter Biomedical Research
Alternative Names: AvirLatest Information Update: 28 Jul 2023
At a glance
- Originator Jupiter Biomedical Research
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Multiple sclerosis; Subacute sclerosing panencephalitis; Viral infections
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for preclinical development in Multiple-sclerosis in Canada (IV, Injection)
- 28 Jul 2023 No recent reports of development identified for preclinical development in Multiple-sclerosis in Canada (PO)
- 28 Jul 2023 No recent reports of development identified for preclinical development in Subacute sclerosing panencephalitis in Canada (IV, Injection)